In connection with its introduction of Claritin^® Liquid, Actress Natasha Rothwell, Who Was Born in Wichita, Calls on Locals to Sign a Petition to Rename City to ‘Wita’, Helping them Ditch the Allergy-Induced Itch

Itching for allergy relief this fall? So are residents of Wichita, Kansas, the No. 1 allergy capital in the United States, according to the Asthma and Allergy Foundation of America (AAFA). This September, Claritin^®, the #1 doctor-recommended non-drowsy oral allergy OTC brand from Bayer, is aiming to take the “itch” out of Wichita and bring relief to its residents with its newest innovation, Claritin^® Liquid. The new product is the only allergy treatment to offer the proven allergy relief of non-drowsy Claritin^® in an instantly soothing Cooling Honey Flavored Liquid, providing 24-hour indoor and outdoor allergy relief of the most irritating allergy symptoms, including itchy throat.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240910619033/en/

Together with new spokesperson, who was born in Wichita and is no stranger to allergy symptoms, Natasha Rothwell, Claritin^® is calling on Wichita residents to sign a petition to change the city’s name to “Wita” in celebration of its new product and its ability to help them ditch the itch. If the petition reaches 1,000 signatures, Claritin^® and Rothwell will pop up in the city to give local allergy sufferers the chance to experience the powerful relief that Claritin^® Liquid provides with 1,000 free product samples (while supplies last).

“I know how frustrating seasonal allergies can be,” said Natasha Rothwell, born in Wichita. “I am excited to come out and help end the itch.”

In addition to offering residents of Wichita free samples of its New Cooling Honey Flavored Liquid if the petition reaches 1,000 signatures, Claritin^® has also committed a monetary donation to the Wichita Parks Foundation to give everyone the chance to enjoy the outdoors.

“Wichita is celebrated as the Air Capital of the World and offers so much to its residents from its vibrant downtown to its beautiful parks, but it’s also notorious for its higher-than-average tree and grass pollen,” said Trevor Thrun, Vice President and General Manager of Upper Respiratory at Bayer. “Claritin remains dedicated to helping allergy sufferers enjoy their lives, and we’re proud to support this commitment by contributing to the Wichita Parks Foundation. Our goal is for everyone to fully enjoy this beautiful city without the discomfort of itchy nose, throat and eyes.”

NEW Claritin^® Liquid provides non-drowsy 24-hour relief from itchy throat or nose, sneezing, runny nose, and itchy, watery eyes that can be triggered by allergens such as pollen, dust mites, pet dander and mold. The product is available in 2.7 and 8.0 fluid-ounce bottles, which can be purchased online at Amazon.com and in-store at retailers nationwide including CVS, Kroger, Walgreens and Walmart. The MSRP ranges from $9.99 - $26.99 USD.

For more information about Claritin^® Liquid, visit www.Claritin.com.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.us.

Bayer U.S. Social Media Channels: Facebook / X / Instagram

Bayer, the Bayer Cross, and Iberogast are trademarks of Bayer.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240910619033/en/